1. Home
  2. CKX vs NCEL Comparison

CKX vs NCEL Comparison

Compare CKX & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CKX Lands Inc.

CKX

CKX Lands Inc.

HOLD

Current Price

$10.31

Market Cap

22.3M

Sector

Energy

ML Signal

HOLD

NCEL

NewcelX Ltd. Ordinary Shares

N/A

Current Price

$3.07

Market Cap

20.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CKX
NCEL
Founded
1930
2008
Country
United States
Switzerland
Employees
N/A
4
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.3M
20.6M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
CKX
NCEL
Price
$10.31
$3.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
15.0K
71.2K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
1125.00
N/A
EPS
0.03
N/A
Revenue
$838,543.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$373.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.66
$1.83
52 Week High
$13.25
$5.12

Technical Indicators

Market Signals
Indicator
CKX
NCEL
Relative Strength Index (RSI) 44.41 47.95
Support Level $10.21 $3.03
Resistance Level $10.78 $3.16
Average True Range (ATR) 0.48 0.39
MACD -0.06 -0.09
Stochastic Oscillator 7.95 8.99

Price Performance

Historical Comparison
CKX
NCEL

About CKX CKX Lands Inc.

CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership of oil and gas royalties, surface leases for farming, the right of way, and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells, and timber income is paid by the highest bidder for the timber. It has small royalty interests in approximately 20 different producing oil and gas fields. Maximum revenue for the company is generated from the Timber segment.

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.

Share on Social Networks: